Around 80% of clinical trials miss enrollment targets. Up to 85% of patients are unaware that participating in a trial was even an option at the time of their diagnosis.
Patient interest is not the problem. Timing is.
When recruitment launches after protocol approval, the most motivated patients have already moved on. They searched for answers during their diagnosis, found little, and redirected their search elsewhere.
The moment someone receives a diagnosis, they begin searching. They join online groups, read patient forums, and look for anything that helps them make sense of what is happening to them. That openness peaks early, not when a recruitment ad finally goes live.
A 2024 analysis in the Journal of Medical Internet Research found that patient engagement through digital platforms is most effective when it begins at the awareness stage, well before active recruitment. Patients who enter recruitment already informed are more motivated, complete screening more often, and are less likely to drop out.
PatientWing's patient recruitment solutions are not about activating a database when a study opens. They are about building relationships and trust with patient communities continuously, long before a protocol exists.
That trust is built through several connected channels.
We publish monthly patient stories from real people living with complex conditions. These stories build trust around the idea of research without overpromising.
We create condition-specific educational pages, explainer videos, and multilingual content that walks patients through their symptoms, diagnosis, and treatment options. This content meets patients where they are, in the language they speak.
.jpeg)
Through our Investigator Profile series, patients meet the researchers behind the science. Seeing the people leading clinical trials helps patients feel informed and confident before they are ever asked to participate.
Through targeted social campaigns, we connect patients with condition-specific communities. Here, research becomes a natural part of the dialogue, without the pressure.
This is just one piece of the puzzle. Learn how PatientWing’s clinical enrollment solutions bridge the gap for sponsors, sites, and, most importantly, the patients who need them.
Sponsors often treat disease awareness as a marketing deliverable. Research tells a different story.
A 2025 study in Gynecologic Oncology Reports found that community-based outreach and early education improved screening volume and reduced screen-failure rates. Patients who understood a trial before arriving at a site asked sharper questions and moved through consent faster.
PatientWing extends disease awareness through patient advocacy partnerships, condition-specific content, and multichannel digital outreach. Patients hear about research from sources they already trust, not just from paid advertising.
.jpeg)
Site coordinators feel the difference immediately. PatientWing-sourced patients arrive understanding what a clinical trial is. They have read about their condition. They have heard from other patients. They have had time to consider whether participation is right for them.
That time matters. Joining a clinical trial is a personal decision. PatientWing creates that space upstream so sites do not have to build it from scratch in a screening room.
PatientWing does not start with your trial. It starts with your patient.
By building condition-specific communities, educating patients about clinical research, and maintaining long-term relationships across 35 countries, our patient recruitment solutions are ready when your study is.
If your next study cannot afford to miss the pre-enrollment window, contact us.
Patient recruitment improves when sponsors build relationships with patients before a study opens. PatientWing's patient-first approach focuses on long-term trust and education, not last-minute outreach.
PatientWing offers a full set of patient recruitment solutions, including clinical trial branding, study websites, patient navigation through screening, and ongoing engagement with patients who hesitate. The goal is to build the trust patients need to enroll and stay.
The most successful patient recruitment companies engage patients long before a trial opens. By the time recruitment begins, those patients are already informed and motivated, which is how PatientWing approaches every study.
Multiple sclerosis (MS) is a chronic disease of the central nervous system (brain and spinal cord) that occurs when the immune system attacks the layer surrounding nerve cells, known as the myelin sheath. When myelin is lost, it damages nerves and disrupts communication between the brain and the rest of the body.
Learn More